Search clinical trials for: hallucinogen

Total 488 results

Radboud University Medical Center
European Union

Completed

The Analgesic Efficacy of Δ9-THC (Namisol®) in Patients With Persistent Postsurgical Abdominal Pain

Chronic Pain | Abdominal Pain | Postsurgical Pain

Netherlands
Radboud University Medical Center
European Union

Completed

Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain

Chronic Pain | Abdominal Pain | Pancreatitis, Chronic

Netherlands
Duke University
Solvay Pharmaceuticals

Completed

A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas

Nausea | Vomiting | Brain Neoplasms

United States
Radboud University Medical Center
Health Valley, Netherlands

Completed

Delta-THC in Dementia

Pain | Dementia | Vascular Dementia | Behavioural Disturbances | Alzheimer's Dementia

Netherlands
Johns Hopkins University

Completed

Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators

Psilocybin | Therapeutic Uses | Psychotropic Drugs | Hallucinogens | Pharmacologic Actions | Central Nervous System Agents

United States
INSYS Therapeutics Inc

Completed

A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users

Drug Abuse, Medication

Canada
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Human Psychopharmacology of Salvinorin A

Healthy

United States
Technical University of Munich
Else Kröner-Fresenius-Foundation; International Unilever-Foundation; Danone... and other collaborators

Completed

Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns

Obesity | Overweight

Germany
Radboud University Medical Center
European Union

Completed

Delta-THC in Behavioral Disturbances in Dementia

Dementia

Netherlands
Radboud University Medical Center

Completed

Safety and Tolerability of Namisol in the Elderly (THC)

Drug Safety

Netherlands
Radboud University Medical Center

Unknown

Perioperative Δ9-THC for Postsurgical Pain (NamiSur)

Pain

Netherlands
Radboud University Medical Center

Completed

Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain (Delta-pain)

Abdominal Pain | Chronic Pancreatitis | Tetrahydrocannabinol | Cannabinoid

Netherlands
Jazz Pharmaceuticals
Quintiles, Inc.

Completed

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. (SPRAY)

Pain | Cancer | Palliative Care

Spain, United Kingdom, United States, Canada, Poland, India, France, Czech Republic, Belgium, Romania, Chile, Finland, Germany, Italy, Mexico, South Africa
California Pacific Medical Center Research Institute

Completed

Placebo Controlled Study of Sublingual Salvinorin A (6A)

Pharmaceutical Preparations
California Pacific Medical Center Research Institute

Completed

Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition. (2C)

MDMA Discontinuation Syndrome

United States
Odense University Hospital

Completed

Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa

Anorexia Nervosa

Denmark
Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome

United States
Brigham and Women's Hospital
Solvay Pharmaceuticals

Completed

Study to Evaluate the Efficacy of Dronabinol (Marinol) as Add-On Therapy for Patients on Opioids for Chronic Pain

Chronic Pain

United States
Michael Camilleri
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome

Irritable Bowel Syndrome

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Effect of Lofexidine and Oral THC on Marijuana Withdrawal and Relapse

Marijuana Dependence

United States
Fundacion para la Investigacion Biomedica del Hospital...
Jazz Pharmaceuticals

Completed

Neuroprotection by Cannabinoids in Huntington's Disease

Huntington's Disease

Spain
University Hospital, Basel, Switzerland

Completed

Pharmacological Interaction Between Clonidine and Methylenedioxymethamphetamine (MDMA)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
University Hospital, Basel, Switzerland

Completed

Interaction Between Duloxetine and 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy)

Substance-Related Disorders | Amphetamine-Related Disorders | Mood Disorder

Switzerland
Hadassah Medical Organization

Unknown

Add on Study on Δ9-THC Treatment for Posttraumatic Stress Disorders (PTSD) (THC_PTSD)

Posttraumatic Stress Disorders

Israel
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Responses to Marijuana-Related Cues Versus Neutral Cues in Adults Taking Tetrahydrocannabinol (THC) - 2

Marijuana Abuse

United States
INSYS Therapeutics Inc

Completed

Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions

Bioavailability

United States
Bionorica Research GmbH

Completed

Efficacy and Safety of the Pain Relieving Effect of Dronabinol in Central Neuropathic Pain Related to Multiple Sclerosis

Central Neuropathic Pain in Multiple Sclerosis

Germany
Par Pharmaceutical, Inc.
BASi Clinical Research Unit

Completed

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

United States
Hadassah Medical Organization
Hebrew University of Jerusalem

Unknown

Efficacy Trial of Oral Tetrahydrocannabinol in Patients With Fibromyalgia

Fibromyalgia

Israel
Alberta Health services
University of Alberta

Completed

Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study

Anorexia | Cancer | Taste Disorders | Olfactory Disorders

Canada
Cantonal Hospital of St. Gallen
ALS Association

Completed

Randomized Placebo-Controlled Crossover Trial With THC (Delta 9-Tetrahydrocannabinol) for the Treatment of Cramps in Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis | Cramps

Switzerland
UMC Utrecht
Leiden University Medical Center; Center for Human Drug Research; TI Pharma

Completed

Investigating the Acute Effects of THC on Functional Brain Systems (FIX)

Magnetic Resonance Imaging | Memory | Reward | Tetrahydrocannabinol | Endocannabinoids

Netherlands
University Health Network, Toronto
Dystonia Medical Research Foundation

Unknown

Efficacy of Dronabinol for the Treatment of Cervical Dystonia

Cervical Dystonia

Canada
National Institute of Allergy and Infectious Diseases...
Bristol-Myers Squibb; Roxane Laboratories

Completed

A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome

HIV Infections | Cachexia | HIV Wasting Syndrome

United States
Ludwig-Maximilians - University of Munich
German Federal Ministry of Education and Research; German Research Network...

Unknown

Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study)

Complex Regional Pain Syndromes | CRPS

Germany
Solvay Pharmaceuticals

Completed

Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting

Chemotherapy Induced Nausea and Vomiting

United States
Solvay Pharmaceuticals

Completed

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

HIV Infections | Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting

United States
University of Manitoba
Valeant Canada Limited

Completed

Randomized Double Blind Cross Over Study for Nabilone in Spasticity in Spinal Cord Injury Persons

Spasticity in Spinal Cord Injured Persons

Canada

Search clinical trials for: hallucinogen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Macedonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations